Report: Anti-Counterfeiting Technology Needs Evolution, Global Implementation

A new study from Cambridge Consultants details some of the challenges facing developers of anti-counterfeiting technology, according to a new white paper written in coordination with the BIO 2010 conference in Chicago.

Summarizing a panel discussion between Lew Kontnik, Director of Brand Protection for Amgen, David Kent, Vice President of Global Risk at Genzyme, Andrew Emmett, director for Science and Regulatory Affairs at BIO, and Hugh Burchett of Cambridge Consultants, the paper reviews current anti-counterfeiting technology – including anti-tamper packaging, serialization and authentication – and concludes all technologies must operate with collaboration among manufacturers, the supply chain and law enforcement to be effective.

The report, which was written as a result of a panel on anti-counterfeiting technology at the 2010 BIO International Convention, highlights the need for new measures to continuously evolve and to wholly integrate with business practices.

According to the release accompanying the report, the research argues that evolving solutions are necessary because counterfeiters have previously demonstrated an ability to adapt to and circumvent one-off approaches.

Additionally, the report emphasizes the necessity of uniform implementation of anti-counterfeiting technology on a global scale, lest counterfeiters avoid newly created measures by moving to less-regulated markets.

The report suggests that this evolution and integration can only be achieved through coordination of customs and law enforcement and adoption of legislation alongside comprehensive public education campaigns.

The white paper is available on Cambridge Consultants’ website.